Outpatient pharmaceutical office: acceto medicines in public health
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.1590/s2175-97902023e21244 http://hdl.handle.net/11449/247315 |
Resumo: | We evaluated the implementation of the outpatient pharmaceutical office in a teaching hospital regarding the access to medicines available in the Unified Health System – SUS. This is a descriptive-analytical study, based on secondary data analysis of 735 appointments performed by the pharmacist from 2015 to 2017. Of the drugs prescribed to patients attended at the outpatient pharmacist office, 86.39% were listed in the National List of Essential Medicines-RENAME, of which 95.43% belonged to the Specialized Component of Pharmaceutical Assistance. Evaluating the patient’s diagnosis against the inclusion criteria of the Clinical Protocols and Therapeutic Guidelines (PCDT), that the most frequent pharmaceutical interventions were: adequacy of the medication request documents (56.4%) and examination requests for pharmacotherapeutic follow up (28.5%). When the prescribed drugs were not included in RENAME/PCDT, the intervention was accepted in 90.3% of the proposals for exchange with available drug in SUS. Still, it was possible to refer the patient to primary care for renewal of continuity of treatment in 95.1% of cases. In conclusion, the role of the clinical pharmacist contributes to the resolution of untreated health problems by promoting access to medicines within the scope of SUS and their rational use in accordance with the PCDT. |
id |
UNSP_94db64dec9918934a6c7e7ef256903c9 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/247315 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Outpatient pharmaceutical office: acceto medicines in public healthAccess to essential medicinesAmbulatory careHealth policyPharmaceutical careUnified health systemWe evaluated the implementation of the outpatient pharmaceutical office in a teaching hospital regarding the access to medicines available in the Unified Health System – SUS. This is a descriptive-analytical study, based on secondary data analysis of 735 appointments performed by the pharmacist from 2015 to 2017. Of the drugs prescribed to patients attended at the outpatient pharmacist office, 86.39% were listed in the National List of Essential Medicines-RENAME, of which 95.43% belonged to the Specialized Component of Pharmaceutical Assistance. Evaluating the patient’s diagnosis against the inclusion criteria of the Clinical Protocols and Therapeutic Guidelines (PCDT), that the most frequent pharmaceutical interventions were: adequacy of the medication request documents (56.4%) and examination requests for pharmacotherapeutic follow up (28.5%). When the prescribed drugs were not included in RENAME/PCDT, the intervention was accepted in 90.3% of the proposals for exchange with available drug in SUS. Still, it was possible to refer the patient to primary care for renewal of continuity of treatment in 95.1% of cases. In conclusion, the role of the clinical pharmacist contributes to the resolution of untreated health problems by promoting access to medicines within the scope of SUS and their rational use in accordance with the PCDT.Hospital Escola Emílio CarlosUniversidade Estadual Paulista – UNESPFaculdade de Medicina de São josé do Rio PretoUniversidade Central de OklahomaSecretaria de Estado da Saúde de São PauloUniversidade Estadual Paulista – UNESPHospital Escola Emílio CarlosUniversidade Estadual Paulista (UNESP)Faculdade de Medicina de São josé do Rio PretoUniversidade Central de OklahomaSecretaria de Estado da Saúde de São PauloMorgado Junior, BelmiroAbreu-Pereira, César Augusto [UNESP]Ponce, Maria Amelia ZanonPagliuso, Rosana De GasperiSantos, Adriana Melo JorgeSimone, Adriane Lopes Medeiros2023-07-29T13:12:45Z2023-07-29T13:12:45Z2023-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1590/s2175-97902023e21244Brazilian Journal of Pharmaceutical Sciences, v. 59.2175-97901984-8250http://hdl.handle.net/11449/24731510.1590/s2175-97902023e212442-s2.0-85158106961Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengBrazilian Journal of Pharmaceutical Sciencesinfo:eu-repo/semantics/openAccess2023-07-29T13:12:46Zoai:repositorio.unesp.br:11449/247315Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T19:06:28.820097Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Outpatient pharmaceutical office: acceto medicines in public health |
title |
Outpatient pharmaceutical office: acceto medicines in public health |
spellingShingle |
Outpatient pharmaceutical office: acceto medicines in public health Morgado Junior, Belmiro Access to essential medicines Ambulatory care Health policy Pharmaceutical care Unified health system |
title_short |
Outpatient pharmaceutical office: acceto medicines in public health |
title_full |
Outpatient pharmaceutical office: acceto medicines in public health |
title_fullStr |
Outpatient pharmaceutical office: acceto medicines in public health |
title_full_unstemmed |
Outpatient pharmaceutical office: acceto medicines in public health |
title_sort |
Outpatient pharmaceutical office: acceto medicines in public health |
author |
Morgado Junior, Belmiro |
author_facet |
Morgado Junior, Belmiro Abreu-Pereira, César Augusto [UNESP] Ponce, Maria Amelia Zanon Pagliuso, Rosana De Gasperi Santos, Adriana Melo Jorge Simone, Adriane Lopes Medeiros |
author_role |
author |
author2 |
Abreu-Pereira, César Augusto [UNESP] Ponce, Maria Amelia Zanon Pagliuso, Rosana De Gasperi Santos, Adriana Melo Jorge Simone, Adriane Lopes Medeiros |
author2_role |
author author author author author |
dc.contributor.none.fl_str_mv |
Hospital Escola Emílio Carlos Universidade Estadual Paulista (UNESP) Faculdade de Medicina de São josé do Rio Preto Universidade Central de Oklahoma Secretaria de Estado da Saúde de São Paulo |
dc.contributor.author.fl_str_mv |
Morgado Junior, Belmiro Abreu-Pereira, César Augusto [UNESP] Ponce, Maria Amelia Zanon Pagliuso, Rosana De Gasperi Santos, Adriana Melo Jorge Simone, Adriane Lopes Medeiros |
dc.subject.por.fl_str_mv |
Access to essential medicines Ambulatory care Health policy Pharmaceutical care Unified health system |
topic |
Access to essential medicines Ambulatory care Health policy Pharmaceutical care Unified health system |
description |
We evaluated the implementation of the outpatient pharmaceutical office in a teaching hospital regarding the access to medicines available in the Unified Health System – SUS. This is a descriptive-analytical study, based on secondary data analysis of 735 appointments performed by the pharmacist from 2015 to 2017. Of the drugs prescribed to patients attended at the outpatient pharmacist office, 86.39% were listed in the National List of Essential Medicines-RENAME, of which 95.43% belonged to the Specialized Component of Pharmaceutical Assistance. Evaluating the patient’s diagnosis against the inclusion criteria of the Clinical Protocols and Therapeutic Guidelines (PCDT), that the most frequent pharmaceutical interventions were: adequacy of the medication request documents (56.4%) and examination requests for pharmacotherapeutic follow up (28.5%). When the prescribed drugs were not included in RENAME/PCDT, the intervention was accepted in 90.3% of the proposals for exchange with available drug in SUS. Still, it was possible to refer the patient to primary care for renewal of continuity of treatment in 95.1% of cases. In conclusion, the role of the clinical pharmacist contributes to the resolution of untreated health problems by promoting access to medicines within the scope of SUS and their rational use in accordance with the PCDT. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-07-29T13:12:45Z 2023-07-29T13:12:45Z 2023-01-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/s2175-97902023e21244 Brazilian Journal of Pharmaceutical Sciences, v. 59. 2175-9790 1984-8250 http://hdl.handle.net/11449/247315 10.1590/s2175-97902023e21244 2-s2.0-85158106961 |
url |
http://dx.doi.org/10.1590/s2175-97902023e21244 http://hdl.handle.net/11449/247315 |
identifier_str_mv |
Brazilian Journal of Pharmaceutical Sciences, v. 59. 2175-9790 1984-8250 10.1590/s2175-97902023e21244 2-s2.0-85158106961 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1808129019937292288 |